Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-008 · synthetic case ADR-FX-10

Repeated joint injections and high-dose inhaled steroid

Non-oral routes count.

Synthetic · no real patientAuthored by Biod · reviewed by Dr. AmaralAdrenal engine v1.0.0

Purpose: Non-oral routes count.

Inputs the engine received

Chemistry and vitals

Age
58 years

Symptoms and signs

Fatigue
Yes

Exposures, history and context

High-dose inhaled, injected or topical glucocorticoid
Yes

What the engine reports

Caution

Glucocorticoid exposure can suppress the adrenal axis

AI-10

Insufficiency is possible, particularly if the dose is reduced or stopped, or during illness. Do not stop glucocorticoids abruptly; any taper is the physician's plan. Provide sick-day guidance and consider testing.

Detected clinical pattern

Glucocorticoid Exposure — Risk of Adrenal Suppression

Exposure that can suppress the adrenal axis is documented. Do not stop abruptly.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Do not stop glucocorticoids abruptly; physician to plan any taper, and provide sick-day guidance.ESE/Endocrine Society 2024.
Evidence and rule trace · 1 rules

AI-10Glucocorticoid exposure

Inputs: high-dose inhaled, injected or topical glucocorticoid

Glucocorticoid-induced adrenal insufficiency is possible.

Evidence

  • EV-ES-GCAI-2024 · Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2024;109(7):1657-1683.

Physician adjudication required. Clinical decision support for physician review. This output identifies laboratory patterns and safety situations. It does not diagnose adrenal insufficiency, name a glucocorticoid dose, or replace emergency treatment. Physician adjudication is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Cortisol testing
  • <5 very likely
  • 5–14.9 indeterminate
  • ≥15 unlikely

46 pg/mL is assumed when empty.

Chemistry and vitals
Symptoms and signs
Exposures, history and context

Live result · computed in your browser

Caution

Glucocorticoid exposure can suppress the adrenal axis

AI-10

Insufficiency is possible, particularly if the dose is reduced or stopped, or during illness. Do not stop glucocorticoids abruptly; any taper is the physician's plan. Provide sick-day guidance and consider testing.

Detected clinical pattern

Glucocorticoid Exposure — Risk of Adrenal Suppression

Exposure that can suppress the adrenal axis is documented. Do not stop abruptly.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Do not stop glucocorticoids abruptly; physician to plan any taper, and provide sick-day guidance.ESE/Endocrine Society 2024.
Evidence and rule trace · 1 rules

AI-10Glucocorticoid exposure

Inputs: high-dose inhaled, injected or topical glucocorticoid

Glucocorticoid-induced adrenal insufficiency is possible.

Evidence

  • EV-ES-GCAI-2024 · Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol Metab. 2024;109(7):1657-1683.

Physician adjudication required. Clinical decision support for physician review. This output identifies laboratory patterns and safety situations. It does not diagnose adrenal insufficiency, name a glucocorticoid dose, or replace emergency treatment. Physician adjudication is required.

More adrenal cases

All adrenal cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod